ArticleBiodegradation2025
Mycotransformation of anthracene by indigenous Trichoderma lixii and Talaromyces pinophilus isolates: insights into the metabolic pathways, enzyme profiles and acute toxicity.
Article in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of Rhizopus stolonifer tolerance to methotrexate: morphological responses and biodegradation limitations.Archives of microbiology · 2026Article
- Deciphering anti-Vibrio potential of Persea americana throughAntonie van Leeuwenhoek · 2026Article
- Diversity, Assembly, and Habitat-Driven Dynamics of Microbial Communities in Eutrophic Dianchi Lake, Southwest China.Microorganisms · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study focused on the mycotransformation of a very prominent PAH, anthracene, and its acute toxicity reduction by Ascomycete fungi: Trichoderma lixii strain FLU1 (TlFLU1) and Talaromyces pinophilus strain FLU12 (TpFLU12), indigenously isolated from benzo[b] fluoranthene-enriched activated sludge. The results indicate that both the isolates TlFLU1 and TpFLU12 could tolerate anthracene exposure up to 1000 mg/L, with increased expression of ligninolytic enzymes: Laccase, Lignin peroxidase, and Manganese peroxidase. The mycotransformation of anthracene was observed to be growth-linked and mediated by the expression of the intracellular enzymes as the initial mechanism used by these strains followed by the ligninolytic enzymes with up to 56% and 38% anthracene degradation by TlFLU1 and TpFLU12, respectively, after 24 days with a concomitant change in pH from 5 to 4 (TlFLU1) and 6.2 (TpFLU12). The GC-MS and FTIR analysis of the samples indicate the appearance of metabolic intermediates: 9,10 anthracenedione and benzoic acid in TlFLU1 grown medium, while anthrone and 9,10 anthracenedione were detected in TpFLU12 grown medium. The mycotransformation of the compound followed a first-order kinetic model with an effective concentration (EC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.